Does VENLAFAXINE Cause Malignant neoplasm progression? 30 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Malignant neoplasm progression have been filed in association with VENLAFAXINE (Venlafaxine Hydrochloride). This represents 0.1% of all adverse event reports for VENLAFAXINE.
30
Reports of Malignant neoplasm progression with VENLAFAXINE
0.1%
of all VENLAFAXINE reports
1
Deaths
11
Hospitalizations
How Dangerous Is Malignant neoplasm progression From VENLAFAXINE?
Of the 30 reports, 1 (3.3%) resulted in death, 11 (36.7%) required hospitalization, and 2 (6.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENLAFAXINE. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does VENLAFAXINE Cause?
Drug ineffective (5,408)
Toxicity to various agents (3,917)
Nausea (2,989)
Completed suicide (2,929)
Headache (2,668)
Dizziness (2,426)
Off label use (2,310)
Overdose (2,220)
Intentional overdose (2,187)
Fatigue (2,153)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which VENLAFAXINE Alternatives Have Lower Malignant neoplasm progression Risk?
VENLAFAXINE vs VENTAVIS
VENLAFAXINE vs VENTOLIN
VENLAFAXINE vs VENTOLIN HFA
VENLAFAXINE vs VERAPAMIL
VENLAFAXINE vs VERICIGUAT